Aastrom Biosciences News
Most Popular Aastrom Biosciences Story
ALSO NOTED: Galapagos gains development grants;Aastrom to sell stock; and much more...
> Galapagos has garnered €5.2 million in grant money to continue its drug development work. Read more...
Latest Headlines
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
